Brexpiprazole versus placebo or other antidepressive agents for treating depression-Reference-Cited by-同舟云学术

Brexpiprazole versus placebo or other antidepressive agents for treating depression

Published:2021-02-05 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Ralovska Silviya¹,Koychev Ivan²,De Crescenzo Franco²,Marinov Petar¹,Cipriani Andrea²³

Affiliation:

1. Department of Neurology, Psychiatry, Physiotherapy and Rehabilitation, Preventive Medicine, and Public Health; Sofia University “St. Kliment Ohridski”; Sofia Bulgaria

2. Department of Psychiatry; University of Oxford; Oxford UK

3. Oxford Health NHS Foundation Trust; Warneford Hospital; Oxford UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference56 articles.

1. Gelenberg AJ Freeman MP Markowitz JC Rosenbaum JF Thase ME Trivedi MJ Work Group on Major Depressive Disorder American Psychiatric Association practice guideline for the treatment of major depressive disorder. 3rd Edition psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf 2010

2. Diagnostic and Statistical Manual of Mental Disorders

3. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. Part 1. Acute and continuation treatment of major depressive disorder;Bauer;World Journal of Biological Psychiatry,2002

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brexpiprazole versus placebo or other antidepressive agents for treating depression;Cochrane Database of Systematic Reviews;2023-07-28

2. Aripiprazole versus brexpiprazole for people with schizophrenia;Cochrane Database of Systematic Reviews;2023-02-17